Court orders publisher OMICS to pay U.S. gov’t $50 million in suit alleging “unfair and deceptive practices”

The U.S. Federal Trade Commission has won a judgment against a publisher and conference organizer that has been widely viewed as predatory.

As reported in brief by Courthouse News Service, U.S. District of Nevada Judge Gloria M. Navarro ordered OMICS International to pay the U.S. government $50,130,810. Among other findings, Navarro writes: Continue reading Court orders publisher OMICS to pay U.S. gov’t $50 million in suit alleging “unfair and deceptive practices”

Russian homeopaths strike again (twice) in virology journal — and a skeptic strikes right back

Alexander Pachin

Homeopathy may not cure disease, but it continues to give journal editors fits, particularly at the hands of a group in Russia that has managed to publish a slew of papers on the spurious practice.

The architect of the effort appears to be one Oleg Epstein, whose company, OOO NPF Materia Medica Holding, makes homeopathic products.

Last May, PLOS ONE retracted a paper by Epstein et al titled “Novel approach to activity evaluation for release-active forms of anti-interferon-gamma antibodies based on enzyme-linked immunoassay.”

The lengthy retraction statement includes the following passages: Continue reading Russian homeopaths strike again (twice) in virology journal — and a skeptic strikes right back

Elsevier looking into how “unorthodox” paper featuring ancient astronauts was published

Elsevier is looking into how one of its journals published a paper which makes bizarre claims about the knowledge of the ancients and contains an acronym with unmistakable and horrific historical significance.

The article, “Puratana Aakasha-Yantrika Nirmana Sadhanavasthu (Ancient Aero-mechanical manufacturing materials),” appeared in a 2017 issue of Materials Today Proceedings and was written by a group of aeronautical engineers in India.

The abstract states: Continue reading Elsevier looking into how “unorthodox” paper featuring ancient astronauts was published

A real headache: Here’s one from the “What else could go wrong?” files

Researchers in China have retracted a 2016 paper in Oncology Letters on the anti-cancer properties of aspirin because, well, it was a disaster from top to bottom.

In the spirit of showing rather than telling, we’ll let the retraction notice do the work: Continue reading A real headache: Here’s one from the “What else could go wrong?” files

When a paper duplicates one in another language, how can editors spot it?

By Petr Kratochvil

Same tea, different mug. Biomolecules, an MDPI journal, has retracted a 2018 paper by on the salubrious effects of tea because the authors had previously published the same article in a Chinese-language journal.

The paper, “Evaluation of anti-obesity activity, acute toxicity, and subacute toxicity of probiotic dark tea,” came from researchers in China and one from Harvard University (oddly, a post-doc in applied physics).

The case highlights a plagiarism problem that may may be difficult to spot, it turns out. According to the retraction notice, the authors were using the same tea leaves in a different cup: Continue reading When a paper duplicates one in another language, how can editors spot it?

Journal temporarily withdraws eight papers after publisher mistake

Publishers love their embargoes, whether they’re of papers that aren’t open access yet, or are available to the media before they’re published. Apparently, however, they also break embargoes, just like the journalists they sometimes sanction for the same sin.

Take Oxford University Press, which publishes the journal Physical Therapy for the American Physical Therapy Association (APTA). Late last month, the journal temporarily withdrew eight papers because, well, the publisher broke the journal’s embargo. Jan Reynolds, the APTA’s managing editor for the journal and director of scientific communications, explained to Retraction Watch that Continue reading Journal temporarily withdraws eight papers after publisher mistake

Journal retracts creationist paper “because it was published in error”

Charles Darwin

It’s become a sort of Retraction Watch Mad Libs: Author writes a paper that is so far, far, out of the mainstream. Maybe it argues that HIV doesn’t cause AIDS. Or that vaccines cause autism. Truth squads swarm over the paper, taking to blogs and Twitter to wonder, in the exasperated tone of those who have been here before, how on earth it was published in a peer reviewed journal.

Then, in something that approaches — but does not quite qualify as — contrition, the journal in question retracts the paper, mumbling something in a retraction notice about a compromised peer review process, or that ghosts in the machine allowed the paper to be published instead of being rejected.

This week’s parade float entry is a paper in the International Journal of Anthropology and Ethnology, a Springer Nature title that is apparently sponsored by The Institute of Ethnology and Anthropology at the Chinese Academy of Social Sciences, where many of its editorial board members work.

Here’s how Jerry Coyne, a researcher at the University of Chicago who keeps an eye on creationists, described the paper, “A brief history of human evolution: challenging Darwin’s claim,” written by Sarah Umer, in a December 18, 2018 post: Continue reading Journal retracts creationist paper “because it was published in error”

Author, author? Dispute over authorship leads to two retraction notices, and confusion

Testosterone

An endocrinology journal has pulled a 2017 paper by a group from Russia and Romania because, well, maybe it’s just better if you read for yourself.

The article, “Testosterone promotes anxiolytic-like behavior in gonadectomized male rats via blockade of the 5-HT1A receptors,” appeared in General and Comparative Endocrinology, an Elsevier publication.

The paper in fact has two retraction notices. One, which is rather less informative than the second, reads: Continue reading Author, author? Dispute over authorship leads to two retraction notices, and confusion

Found in translation: Authors blame language barriers after forging co-authors

When the merde hits the fan, blame the translator. That’s Rule 1 of botched international diplomacy — and, evidently, botched international science.

Otolaryngology researchers in China have lost their 2018 paper in the American Journal of Translational Research for what they’re calling (with some degree of chutzpah) language barriers.

The article, “Therapeutic ultrasound potentiates the anti-nociceptive and anti-inflammatory effects of curcumin to postoperative pain via Sirt1/NF-κB signaling pathway,” came from group whose primary affiliation was the Second Military Medical University in Shanghai. (It hasn’t been cited, according to Clarivate’s Web of Science.) However, the list of authors also included several scientists in Germany.

Evidently, the Germans were most unzufrieden.

According to the retraction notice: Continue reading Found in translation: Authors blame language barriers after forging co-authors

A reviewer stole a manuscript and published it himself. But you wouldn’t know it from this retraction notice.

The Taylor & Francis logo

Fish off someone else’s peer review!

So writes (in somewhat different words) Mina Mehregan, a mechanical engineer at Ferdowsi University of Mashhad in Iran. Mehregan and a colleague recently discovered that they’d been victimized by a group of unscrupulous reviewers who used the pretext of a long turnaround time to publish a hijacked version of their manuscript in another journal.

In a guest editorial for the Journal of Korean Medical Science — which wasn’t involved in the heist — Mehregan began by noting the toll that protracted peer review can take on authors: Continue reading A reviewer stole a manuscript and published it himself. But you wouldn’t know it from this retraction notice.